Bayer to buy AskBio in deal worth up to $4B
October 26, 2020 at 12:04 PM EDT
The global pharmaceutical company is buying a North Carolina-based gene-therapy outfit in a deal that could reach as high as $4 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|